PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...
Join PanCAN on Jan. 30, at 11 a.m. PT / 2 p.m. ET, for an educational discussion about pancreatic cancer clinical trials and ...
On World Pancreatic Cancer Day, hundreds of patients, caregivers and loved ones tuned in for our special virtual event, “How Early Detection Can Change the Course for Pancreatic Cancer.” Our guests ...
The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...
A device already approved to treat several other types of cancer has shown positive results for a subset of patients with pancreatic cancer. In a Phase III clinical trial, a therapy known as Tumor ...
Contact a PanCAN Patient Services Case Manager for up-to-date information about pancreatic cancer, clinical trial searches, personalized medicine and support resources. All information and services ...
PanCAN is leading large-scale, groundbreaking research initiatives that will be the catalyst for transforming the way pancreatic cancer is detected and treated. No single pancreatic cancer ...
PanCAN’s Precision Promise Clinical Trial Consortium sites were selected through a competitive, peer-review process and include premier cancer treatment institutions across the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback